Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 8/20 | 0.64 |
| ▸ | S100A4 | P26447 | 2/20 | 0.59 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.46 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTR2B | P41595 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20924856 | 0.79 | ACHE (0.59) | ACHES100A4LMNATP53CYP1A2 | |
| SCHEMBL9372008 | 0.78 | ACHE (0.48) | ACHES100A4CSNK2A2CSNK2A1TSHR | |
| SCHEMBL181579 | 0.78 | ACHE (0.48) | ACHES100A4CSNK2A2CSNK2A1TSHR | |
| SCHEMBL31326549 | 0.78 | ACHE (0.48) | ACHES100A4CSNK2A2CSNK2A1TSHR | |
| SCHEMBL9752693 | 0.78 | ACHE (1.00) | ACHETSHRCYP19A1 | |
| SCHEMBL9367273 | 0.78 | ACHE (0.48) | ACHES100A4CSNK2A2CSNK2A1TSHR | |
| SCHEMBL4938272 | 0.78 | ACHE (1.00) | ACHETSHRCYP19A1 | |
| SCHEMBL20368206 | 0.78 | ACHE (0.48) | ACHES100A4CSNK2A2CSNK2A1TSHR | |
| SCHEMBL354925 | 0.78 | ACHE (1.00) | ACHETSHRCYP19A1 | |
| SCHEMBL13866434 | 0.78 | ACHE (1.00) | ACHETSHRCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115582131-B | Copper-manganese catalyst and preparation method and application thereof | 浙江新和成股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-113862034-B | Method for synthesizing high-density aviation kerosene from biomass diene and p-benzoquinone in one pot | 中国科学院大连化学物理研究所 | 2023-11-07 | — | — | CN | claimed |
| CN-116462588-A | Preparation method of vitamin K4 | 浙江新和成药业有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-111689844-B | Novel production process of 2-methyl-1, 4-naphthoquinone | 能特科技有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-116102413-A | Preparation method of 2-methyl-1, 4-naphthoquinone and intermediate thereof | 浙江大学 | 2023-05-12 | — | — | CN | claimed |
| CN-116102414-A | Preparation method of benzoquinone compound and 2-methyl-1, 4-naphthoquinone | 浙江大学 | 2023-05-12 | — | — | CN | claimed |
| CN-115805096-B | Heterogeneous nitrogen-doped carbon material supported cobalt catalyst and vitamin K 3 Is produced by the production process of (2) | 浙江新和成股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-115805096-A | Heterogeneous nitrogen-doped carbon material supported cobalt catalyst and vitamin K 3 Production process of | 浙江新和成股份有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-115582131-A | Copper-manganese catalyst and preparation method and application thereof | 浙江新和成股份有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-111689844-A | Novel production process of 2-methyl-1, 4-naphthoquinone | 能特科技有限公司 | 2020-09-22 | — | — | CN | claimed |
| CN-117865787-A | Crystal form I of menatetrenone and preparation method thereof | 郑州泰丰制药有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-115582131-B | Copper-manganese catalyst and preparation method and application thereof | 浙江新和成股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-113862034-B | Method for synthesizing high-density aviation kerosene from biomass diene and p-benzoquinone in one pot | 中国科学院大连化学物理研究所 | 2023-11-07 | — | — | CN | disclosed |
| CN-116462588-A | Preparation method of vitamin K4 | 浙江新和成药业有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-116462588-A | Preparation method of vitamin K4 | 浙江新和成药业有限公司 | 2023-07-21 | — | — | CN | disclosed |
| US-20090264563-A1 | USE OF A SPECIFIC PLATINUM COMPOUND IN ORDER TO IMPROVE THE RESISTANCE OF SILICON ELASTOMERS TO DEGREDATION CAUSED BY VERY HIGH TEMPERATURES | RHONDA CHIME (FR) | 2009-10-22 | — | — | US | disclosed |
| US-7202320-B2 | Silicone composition crosslinkable into elastomer by hydrosilylation, in the presence of carbene-based metal catalysts, and catalysts | RHODIA CHIMIE (FR) | 2007-04-10 | — | — | US | disclosed |
| US-7202320-B2 | Silicone composition crosslinkable into elastomer by hydrosilylation, in the presence of carbene-based metal catalysts, and catalysts | RHODIA CHIMIE (FR) | 2007-04-10 | — | — | US | disclosed |
| EP-0866692-A1 | USE OF BICYCLIC MONO- OR DIKETONE DERIVATIVES, RESULTING COMPOUNDS, AND USE THEREOF AS A DRUG FOR TREATING INFLAMMATION, MIGRAINE AND SHOCK | LABORATOIRE INNOTHERA Société Anonyme (FR) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997021432-A1 | USE OF BICYCLIC MONO- OR DIKETONE DERIVATIVES, RESULTING COMPOUNDS, AND USE THEREOF AS A DRUG FOR TREATING INFLAMMATION, MIGRAINE AND SHOCK | LABORATOIRE INNOTHERA, S.A. (FR) | 1997-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264563-A1 | USE OF A SPECIFIC PLATINUM COMPOUND IN ORDER TO IMPROVE THE RESISTANCE OF SILICON ELASTOMERS TO DEGREDATION CAUSED BY VERY HIGH TEMPERATURES | XRCC5, PPOX, GPX4 | ACHE 2079/4885S100A4 3456/4885CSNK2A2 3249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.